Publications by authors named "Georgios Aislaitner"

Claim this Profile
T
Tofersen for SOD-1-associated amyotrophic lateral sclerosis.
Marion Haberkamp, Georgios Aislaitner, Elena H Martínez-Lapiscina, Martina Weise

Lancet Neurol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The new European Medicines Agency guideline on antidepressants: a guide for researchers and drug developers.
Florence Butlen-Ducuing, Marion Haberkamp, Georgios Aislaitner, Ewa Bałkowiec-Iskra, Taina Mattila

Eur Psychiatry· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The therapeutic potential of psychedelics: the European regulatory perspective.
Florence Butlen-Ducuing, Drummond E-Wen McCulloch, Marion Haberkamp, Taina Mattila, Ewa Bałkowiec-Iskra, Georgios Aislaitner

Lancet· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trials.
Luca Sforzini, Courtney Worrell, Melisa Kose, Ian M Anderson, Bruno Aouizerate, Georgios Aislaitner

Mol Psychiatry· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis